A phase III randomized trial of induction chemotherapy and pembrolizumab followed by chemoradiation and pembrolizumab maintenance versus standard chemoradiation and pembrolizumab maintenance in high-risk locally advanced cervical cancer

Authors

• Theresa Kuhn MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

5-2026

Volume

44

Published In/Presented At

DOI:10.1200/JCO.2026.44.16_suppl.TPS5632

Disciplines

Medicine and Health Sciences

Department(s)

Department of Obstetrics and Gynecology

Document Type

Article